cbdMD, Inc. has announced new compensation terms for its board of directors, effective from April 11, 2025. Each independent director and the non-management employee director will receive 1,572 restricted stock units (RSUs) as compensation for their services. These RSUs will vest quarterly, with the first vesting date set for June 30, 2025, and the final one on March 31, 2026. The RSUs were granted under the company's 2015 and 2021 Equity Compensation Plan, and their value will be based on the company's stock closing price as of May 16, 2025. Additionally, cbdMD's board has approved annual cash retainers of $35,000 for each independent director, with extra compensation for committee chairs and members. The Chairman of the Board will receive an additional $26,500, the Chairman of the Audit Committee $17,000, and the Chairman of the Compensation, Corporate Governance and Nominating Committee $7,000. Audit Committee members, excluding the chairperson, will receive an extra $8,500, while members of the Compensation, Corporate Governance and Nominating Committee will receive an additional $4,000.